Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5068557 | 1.00 | ITGB1 (0.78) | ITGB1ITGA4 | |
| SCHEMBL5065590 | 0.92 | ITGB1 (0.66) | ITGB1ITGA4 | |
| SCHEMBL5065587 | 0.92 | ITGB1 (0.66) | ITGB1ITGA4 | |
| SCHEMBL5066817 | 0.87 | ITGB1 (1.00) | ITGB1ITGA4 | |
| SCHEMBL5066820 | 0.87 | ITGB1 (1.00) | ITGB1ITGA4 | |
| SCHEMBL5069285 | 0.87 | ITGB1 (1.00) | ITGB1ITGA4 | |
| SCHEMBL5068105 | 0.86 | ITGB1 (0.68) | ITGB1ITGA4 | |
| SCHEMBL5068111 | 0.86 | ITGB1 (0.68) | ITGB1ITGA4 | |
| SCHEMBL5068108 | 0.86 | ITGB1 (0.68) | ITGB1ITGA4 | |
| SCHEMBL5067755 | 0.81 | ITGB1 (0.51) | ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234301-A1 | Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234301-A1 | Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases | ITGB4, ITGA4, ICAM1 | ITGB1 5/4885ITGA4 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.